Video

Dr. Salani on Therapeutic Advances in Endometrial Cancer

Author(s):

Ritu Salani, MD, MBA, discusses therapeutic advances in endometrial cancer.

Ritu Salani, MD, MBA, gynecologic oncologist, University of California, Los Angeles, discusses therapeutic advances in endometrial cancer.

In recent years, immunotherapy has risen to the forefront as a therapeutic option for patients with endometrial cancer, Salani says.

Additionally, the field is developing a greater understanding of how to best utilize immunotherapy in women with endometrial cancer who harbor mismatch repair deficiencies (MMRs) or have Lynch syndrome, explains Salani.

Additionally, combination regimens, such as pembrolizumab (Keytruda) plus lenvatinib (Lenvima), have demonstrated notable response rates among patients without MMRs, Salani says. However, the combination is associated with toxicity, so it’s important to consider the relative risks and benefits of the combination on an individualized basis. 

Other advances, such as combining hormonal therapy with mTOR inhibitors and utilizing trastuzumab (Herceptin) in patients with serous endometrial cancer who harbor HER2/neu mutations, are continuing to push the field forward, concludes Salani.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity